Citations (20)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Roberto Mandrioli & Laura Mercolini. (2015) Discontinued anxiolytic drugs (2009 – 2014). Expert Opinion on Investigational Drugs 24:4, pages 557-573.
Read now
Read now
Articles from other publishers (19)
Miroslav Adzic, Iva Lukic, Milos Mitic, Emilija Glavonic, Nina Dragicevic & Sanja Ivkovic. (2023) Contribution of the opioid system to depression and to the therapeutic effects of classical antidepressants and ketamine. Life Sciences 326, pages 121803.
Crossref
Crossref
Daisuke Yamada & Akiyoshi Saitoh. (2022) Neural mechanism underlying the regulation of emotional behavior via δ-opioid receptorsδオピオイド受容体を介した情動行動制御とその神経メカニズム. Folia Pharmacologica Japonica 157:6, pages 448-452.
Crossref
Crossref
Yuka Uenohara, Saori Tsumura, Shigeto Hirayama, Eika Higashi, Yurie Watanabe, Hiroaki Gouda, Hiroshi Nagase & Hideaki Fujii. (2022) Morphinan derivatives with an oxabicyclo[3.2.1]octane structure as dual agonists toward δ and κ opioid receptors. Bioorganic & Medicinal Chemistry 53, pages 116552.
Crossref
Crossref
Lucia Moravcikova, Roman Moravcik, Daniela Jezova, Lubica Lacinova & Eliyahu Dremencov. (2020) Delta-opioid receptor-mediated modulation of excitability of individual hippocampal neurons: mechanisms involved. Pharmacological Reports 73:1, pages 85-101.
Crossref
Crossref
Hiroshi Nagase & Akiyoshi Saitoh. (2020) Research and development of κ opioid receptor agonists and δ opioid receptor agonists. Pharmacology & Therapeutics 205, pages 107427.
Crossref
Crossref
Fumika Karaki, Sho Umemoto, Karin Ashizawa, Tomoya Oki, Noriko Sato, Takumi Ogino, Naoto Ishibashi, Ryoto Someya, Kanako Miyano, Shigeto Hirayama, Yasuhito Uezono & Hideaki Fujii. (2019)
A New Lead Identification Strategy: Screening an sp
3
‐rich and Lead‐like Compound Library Composed of 7‐Azanorbornane Derivatives
. ChemMedChem 14:21, pages 1840-1848.
Crossref
Crossref
Tsutomu Suzuki, Takuko Sawada, Koji Kawai & Yasunobu Ishihara. (2018) Pharmacological profile of TAN-452, a novel peripherally acting opioid receptor antagonist for the treatment of opioid-induced bowel syndromes. Life Sciences 215, pages 246-252.
Crossref
Crossref
Lorella Pasquinucci, Rita Turnaturi, Orazio Prezzavento, Emanuela Arena, Giuseppina Aricò, Zafiroula Georgoussi, Rosalba Parenti, Giuseppina Cantarella & Carmela Parenti. (2017) Development of novel LP1-based analogues with enhanced delta opioid receptor profile. Bioorganic & Medicinal Chemistry 25:17, pages 4745-4752.
Crossref
Crossref
Yoshikazu Watanabe, Kohei Hayashida, Daisuke Saito, Toshihiro Takahashi, Junichi Sakai, Eriko Nakata, Takashi Kanda, Takashi Iwai, Shigeto Hirayama, Hideaki Fujii, Tomio Yamakawa & Hiroshi Nagase. (2017) Design and synthesis of novel δ opioid receptor agonists with an azatricyclodecane skeleton for improving blood-brain barrier penetration. Bioorganic & Medicinal Chemistry Letters 27:15, pages 3495-3498.
Crossref
Crossref
Kohei Hayashida, Shigeto Hirayama, Takashi Iwai, Yoshikazu Watanabe, Toshihiro Takahashi, Junichi Sakai, Eriko Nakata, Tomio Yamakawa, Hideaki Fujii & Hiroshi Nagase. (2017) Novel delta opioid receptor agonists with oxazatricyclodecane structure showing potent agonistic activities. Bioorganic & Medicinal Chemistry Letters 27:12, pages 2742-2745.
Crossref
Crossref
Bálint Botz, Kata Bölcskei & Zsuzsanna Helyes. (2016) Challenges to develop novel anti‐inflammatory and analgesic drugs. WIREs Nanomedicine and Nanobiotechnology 9:3.
Crossref
Crossref
Tyler A. Johnson, Laura Milan-Lobo, Tao Che, Madeline Ferwerda, Eptisam Lambu, Nicole L. McIntosh, Fei Li, Li He, Nicholas Lorig-Roach, Phillip Crews & Jennifer L. Whistler. (2016) Identification of the First Marine-Derived Opioid Receptor “Balanced” Agonist with a Signaling Profile That Resembles the Endorphins. ACS Chemical Neuroscience 8:3, pages 473-485.
Crossref
Crossref
Andrew Charles & Amynah A. Pradhan. (2016) Delta-opioid receptors as targets for migraine therapy. Current Opinion in Neurology 29:3, pages 314-319.
Crossref
Crossref
Nunzio Vicario, Rosalba Parenti, Giuseppina Aricò, Rita Turnaturi, Giovanna Maria Scoto, Santina Chiechio & Carmela Parenti. (2016) Repeated activation of delta opioid receptors counteracts nerve injury-induced TNF-α up-regulation in the sciatic nerve of rats with neuropathic pain. Molecular Pain 12, pages 174480691666794.
Crossref
Crossref
Akiyoshi Saitoh & Hiroshi Nagase. 2018. Delta Opioid Receptor Pharmacology and Therapeutic Applications. Delta Opioid Receptor Pharmacology and Therapeutic Applications
3
19
.
Giovanni Loriga, Paolo Lazzari, Ilaria Manca, Stefania Ruiu, Matteo Falzoi, Gabriele Murineddu, Mirko Emilio Heiner Bottazzi, Giovanni Pinna & Gérard Aimè Pinna. (2015) Novel diazabicycloalkane delta opioid agonists. Bioorganic & Medicinal Chemistry 23:17, pages 5527-5538.
Crossref
Crossref
Toru Nemoto, Yusuke Iihara, Shigeto Hirayama, Takashi Iwai, Eika Higashi, Hideaki Fujii & Hiroshi Nagase. (2015) Naltrindole derivatives with fluorinated ethyl substituents on the 17-nitrogen as δ opioid receptor inverse agonists. Bioorganic & Medicinal Chemistry Letters 25:15, pages 2927-2930.
Crossref
Crossref
Paul Klenowski, Michael Morgan & Selena E Bartlett. (2015) The role of δ-opioid receptors in learning and memory underlying the development of addiction. British Journal of Pharmacology 172:2, pages 297-310.
Crossref
Crossref
Hideaki Fujii, Kohei Hayashida, Akiyoshi Saitoh, Akinobu Yokoyama, Shigeto Hirayama, Takashi Iwai, Eriko Nakata, Toru Nemoto, Yuka Sudo, Yasuhito Uezono, Mitsuhiko Yamada & Hiroshi Nagase. (2014) Novel Delta Opioid Receptor Agonists with Oxazatricyclodecane Structure. ACS Medicinal Chemistry Letters 5:4, pages 368-372.
Crossref
Crossref